Holen Sie sich die Stockscreener-App
18.64
0.65%
0.12
Vorhandelsmarkt:
18.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$18.52
Offen:
$18.5
24-Stunden-Volumen:
1.69M
Relative Volume:
0.58
Marktkapitalisierung:
$3.71B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-185.00M
KGV:
-18.46
EPS:
-1.01
Netto-Cashflow:
$364.00M
1W Leistung:
+4.31%
1M Leistung:
-23.70%
6M Leistung:
-33.90%
1J Leistung:
-39.85%
1-Tages-Spanne:
$18.32
$18.79
1-Wochen-Bereich:
$17.73
$19.11
52-Wochen-Spanne:
$17.21
$37.60
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| XRAY | 18.64 | 3.71B | 3.90B | -185.00M | 364.00M | -1.01 |
| ISRG | 550.62 | 194.93B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 225.45 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.57 | 42.36B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 243.60 | 35.51B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 320.88 | 22.81B | 2.88B | 499.60M | 321.60M | 7.41 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Zirconia for Dental Use Market Analysis By Top Keyplayers - openPR
Dentsply Sirona Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Investigation of XRAY: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Investors with Significant Losses to Contact the Firm - AccessWire
John G Ullman & Associates Inc. Purchases 109,083 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $29.50 - MarketBeat
Dentsply Sirona Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Dental Alloys Market Valuation Outlook See Stable Growth Ahead: Dentsply Sirona, Aalba Dent Inc - openPR
Nuance Investments LLC Sells 42,032 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
Leerink Partners Downgrades DENTSPLY SIRONA (XRAY) - MSN
Dentsply Sirona downgraded at Leerink after guidance cut - MSN
91,187 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by Empowered Funds LLC - MarketBeat
Bio-implant Market Growth in Future Scope 2024-2031 | Abbott., Dentsply Sirona Plc., Medtronic, Stryker Corporation - openPR
Dentsply Sirona Inc. stock outperforms competitors on strong trading day - MarketWatch
XRAY Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Investors with Significant Losses to Contact the Firm - AccessWire
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stake Decreased by Sasco Capital Inc. CT - MarketBeat
113,319 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Acquired by LMR Partners LLP - MarketBeat
Acrylic Teeth Market Growth in Future Scope 2024-2031 | Dentsply - openPR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc.XRAY - PR Newswire
Dentsply Sirona Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Dentsply Sirona director Gregory Lucier buys $110,128 in stock By Investing.com - Investing.com Canada
Dentsply Sirona director Gregory Lucier buys $110,128 in stock - Investing.com
XRAY Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Investors with Significant Losses to Contact the Firm - AccessWire
Cosmetic Implants Market Sales and Revenue, Segmentation - openPR
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Quest Partners LLC - MarketBeat
Abutment Implants Market 2024-2031 Revenues Will Increase - openPR
NASDAQ: XRAY Investigation Reminder: Kessler Topaz Meltzer - GlobeNewswire
NASDAQ: XRAY Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm - GlobeNewswire Inc.
NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm - The Malaysian Reserve
Cone Beam Computed Tomography Market Set for Rapid Expansion - openPR
Dental Imaging Market Growth in Future Scope 2024-2031 | - openPR
Dental Dam Market Future Business Opportunities 2024-2031 | - openPR
DENTSPLY SIRONA (NASDAQ:XRAY) Shares Gap UpShould You Buy? - MarketBeat
Strategy To YieldBoost XRAY From 3.6% To 12.2% Using Options - Nasdaq
Dental Stimulator Market Share, Trends, Top Players, Segments - openPR
Dental Chairs Market Size, Trends, Growth, Opportunities - openPR
Fuller & Thaler Asset Management's Strategic Acquisition of Dent - GuruFocus.com
Insider Buying: Simon Campion Acquires Shares of Dentsply Sirona Inc (XRAY) - GuruFocus.com
Dentsply Sirona CEO Simon Campion buys $200,341 in stock - Investing.com
Dentures Market Is Booming Worldwide 2024-2031 | Dentsply - openPR
First Eagle Investment Bolsters Position in Dentsply Sirona Inc - GuruFocus.com
Artisan Partners Limited Partnership Bolsters Stake in Dentsply Sirona Inc - GuruFocus.com
Transforming cleft care: non-profit, dental giant use portable scanners to reach remote communities - Oral Health
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation - AccessWire
Dentsply Sirona Inc. stock underperforms Monday when compared to competitors - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - AccessWire
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - Simply Wall St
Principal Financial Group Inc. Decreases Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
DENTSPLY SIRONA Q4 EPS Estimate Lowered by Leerink Partnrs - MarketBeat
Q1 EPS Estimates for DENTSPLY SIRONA Lowered by Analyst - MarketBeat
William Blair Predicts Reduced Earnings for DENTSPLY SIRONA - MarketBeat
Dental Implants Market Overall Study Report 2024-2031 | - openPR
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):